AstraZeneca

AstraZeneca pays $50 million for rights to Merck cancer drug
Yahoo/Reuters
Wed, 09/11/13 - 08:50 am
Merck
AstraZeneca
ovarian cancer
MK-1775
AstraZeneca reverses $285 mln charge as cancer trial starts
Reuters
Wed, 09/4/13 - 09:19 am
AstraZeneca
olaparib
ovarian cancer
AstraZeneca Reports Onglyza Data
Yahoo/Zacks
Wed, 09/4/13 - 08:57 am
Onglyza
AstraZeneca
diabetes
Is 'No Worse Than Placebo' Good Enough For New Diabetes Drugs?
Forbes
Tue, 09/3/13 - 11:07 am
diabetes
saxagliptin
alogliptin
AstraZeneca
Bristol-Myers Squibb
Takeda
Study finds patients often stop using new AstraZeneca heart drug
Reuters
Tue, 09/3/13 - 10:31 am
Brilinta
AstraZeneca
3 PDUFA Dates That Will Kick Off 2014
Motley Fool
Tue, 08/27/13 - 05:34 pm
FDA
diabetes
Forixga
Bristol-Myers Squibb
AstraZeneca
Biomarin
Vimizim
Amylin
metreleptin
AstraZeneca - Small Deal With Amplimmune Provides No Quick Fixes
Seeking Alpha
Tue, 08/27/13 - 09:09 am
AstraZeneca
Amplimmune
M&A
AstraZeneca forges $500M cancer-combo tech buyout for MedImmune
Fierce Biotech
Mon, 08/26/13 - 09:34 am
MedImmune
AstraZeneca
M&A
AstraZeneca to buy U.S. cancer firm for up to $500 mln
Reuters
Mon, 08/26/13 - 09:26 am
AstraZeneca
M&A
Amplimmune
3 New Diabetes Drugs Possibly on the Way Soon
Motley Fool
Wed, 08/21/13 - 09:03 am
diabetes
Forixga
AstraZeneca
Bristol-Myers Squibb
dulaglutide
Eli Lilly
Afrezza
MannKind
These drugs are the cash cows of big pharma
Quartz
Tue, 08/20/13 - 12:20 pm
JNJ
Novartis
Pfizer
Merck
Roche
Bayer
Sanofi
GSK
Abbott Labs
AstraZeneca
Eli Lilly
How Much To Develop A Drug? An Update
Seeking Alpha
Mon, 08/12/13 - 11:51 am
R&D
AstraZeneca
Bayer
Eli Lilly
Novartis
Pfizer
Regeneron
Roche
Shire
Takeda
Can AstraZeneca's New Strategy Save Its Stock?
Motley Fool
Sat, 08/10/13 - 12:25 pm
AstraZeneca
Revenue, Earnings And Profits All Fall At AstraZeneca Plc
Motley Fool
Thu, 08/1/13 - 08:50 am
AstraZeneca
earnings
2 Keys to Success for This Diabetes Drug's Second Chance
Motley Fool
Tue, 07/30/13 - 11:35 am
diabetes
AstraZeneca
Bristol-Myers Squibb
Forxiga
AstraZeneca, Bristol resubmit NDA for diabetes therapy dapagliflozin
Fierce Biotech
Thu, 07/25/13 - 11:16 am
diabetes
Dapagliflozin
Bristol-Myers Squibb
AstraZeneca
[video] Onyx Prepares for Multiple Bids After Amgen Snub
Bloomberg
Tue, 07/23/13 - 11:00 am
ONYX Pharmaceuticals
Amgen
M&A
AstraZeneca
Pfizer
Novartis
The Diabetes Pipeline With a Clog
Motley Fool
Mon, 07/22/13 - 06:02 pm
diabetes
AstraZeneca
Bristol-Myers Squibb
Eli Lilly
JNJ
SGLT2 inhibitor
Forxiga
Invokana
empagliflozin
AstraZeneca, Pfizer among possible bidders for Onynx, Bloomberg reports
Yahoo/Fly on the Wall
Mon, 07/22/13 - 05:59 pm
Pfizer
AstraZeneca
ONYX Pharmaceuticals
M&A
ChinaGate: Glaxo Issues A Mea Culpa And AstraZeneca Is Questioned
Pharmalot
Mon, 07/22/13 - 11:29 am
GSK
China
AstraZeneca

Pages